Clinical Trial Update: Clinical Trial to Evaluate Safety and Efficacy of Cell Therapy in Patients With Cicatricial Conjuntivitis. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and potential efficacy of a cell therapy in patients with cicatricial conjunctivitis and related conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Conjunctivitis
• Ocular Cicatricial Pemphigoid
• Stevens-johnson Syndrome
• Toxic Epidermal Necrolysis

Snippet

Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz | Conditions: Chronic Conjunctivitis, Stevens-Johnson Syndrome | Phase 1, Phase 2 | Status: UNKNOWN